|
1
|
Schröder O, Mickisch O, Seidler U, de
Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge
U, Schrott M and Stein J: Intravenous iron sucrose versus oral iron
supplementation for the treatment of iron deficiency anemia in
patients with inflammatory bowel disease-a randomized, controlled,
open-label, multicenter study. Am J Gastroenterol. 100:2503–2509.
2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rozen-Zvi B, Gafter-Gvili A, Paul M,
Leibovici L, Shpilberg O and Gafter U: Intravenous versus oral iron
supplementation for the treatment of anemia in CKD: Systematic
review and meta-analysis. Am J Kidney Dis. 52:897–906.
2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sultan P, Bampoe S, Shah R, Guo N, Estes
J, Stave C, Goodnough LT, Halpern S and Butwick AJ: Oral vs
intravenous iron therapy for postpartum anemia: A systematic review
and meta-analysis. Am J Obstet Gynecol. 221:19–29.e3.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lewkowitz AK, Gupta A, Simon L, Sabol BA,
Stoll C, Cooke E, Rampersad RA and Tuuli MG: Intravenous compared
with oral iron for the treatment of iron-deficiency anemia in
pregnancy: A systematic review and meta-analysis. J Perinatol.
39:519–532. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Moon T, Smith A, Pak T, Park BH, Beutler
SS, Brown T, Kaye AD and Urman RD: Preoperative anemia treatment
with intravenous iron therapy in patients undergoing abdominal
surgery: A systematic review. Adv Ther. 38:1447–1469.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Shi Q, Leng W, Wazir R, Li J, Yao Q, Mi C,
Yang J and Xing A: Intravenous iron sucrose versus oral iron in the
treatment of pregnancy with iron deficiency anaemia: A systematic
review. Gynecol Obstet Invest. 80:170–178. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Qunibi WY, Martinez C, Smith M, Benjamin
J, Mangione A and Roger SD: A randomized controlled trial comparing
intravenous ferric carboxymaltose with oral iron for treatment of
iron deficiency anaemia of non-dialysis-dependent chronic kidney
disease patients. Nephrol Dial Transplant. 26:1599–1607.
2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Agarwal R, Kusek JW and Pappas MK: A
randomized trial of intravenous and oral iron in chronic kidney
disease. Kidney Int. 88:905–914. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bager P and Dahlerup JF: Randomised
clinical trial: Oral vs. intravenous iron after upper
gastrointestinal haemorrhage-a placebo-controlled study. Aliment
Pharmacol Ther. 39:176–187. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bertani L, Tricò D, Zanzi F, Svizzero GB,
Coppini F, de Bortoli N, Bellini M, Antonioli L, Blandizzi C and
Marchi S: Oral sucrosomial iron is as effective as intravenous
ferric carboxy-maltose in treating anemia in patients with
ulcerative colitis. Nutrients. 13(608)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Birgegård G, Henry D, Glaspy J, Chopra R,
Thomsen LL and Auerbach M: A randomized noninferiority trial of
intravenous iron isomaltoside versus oral iron sulfate in patients
with nonmyeloid malignancies and anemia receiving chemotherapy: The
PROFOUND trial. Pharmacotherapy. 36:402–414. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Das SN, Devi A, Mohanta BB, Choudhury A,
Swain A and Thatoi PK: Oral versus intravenous iron therapy in iron
deficiency anemia: An observational study. J Family Med Prim Care.
9:3619–3622. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Drexler C, Macher S, Lindenau I, Holter M,
Moritz M, Stojakovic T, Pieber TR, Schlenke P and Amrein K:
High-dose intravenous versus oral iron in blood donors with iron
deficiency: The IronWoMan randomized, controlled clinical trial.
Clin Nutr. 39:737–745. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Erichsen K, Ulvik RJ, Nysaeter G, Johansen
J, Ostborg J, Berstad A, Berge RK and Hausken T: Oral ferrous
fumarate or intravenous iron sucrose for patients with inflammatory
bowel disease. Scand J Gastroenterol. 40:1058–1065. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fukao W, Hasuike Y, Yamakawa T, Toyoda K,
Aichi M, Masachika S, Kantou M, Takahishi SI, Iwasaki T, Yahiro M,
et al: Oral versus intravenous iron supplementation for the
treatment of iron deficiency anemia in patients on maintenance
hemodialysis-effect on fibroblast growth factor-23 metabolism. J
Ren Nutr. 28:270–277. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Garrido-Martín P, Nassar-Mansur MI, de la
Llana-Ducrós R, Virgos-Aller TM, Fortunez PM, Ávalos-Pinto R,
Jimenez-Sosa A and Martínez-Sanz R: The effect of intravenous and
oral iron administration on perioperative anaemia and transfusion
requirements in patients undergoing elective cardiac surgery: A
randomized clinical trial. Interact Cardiovasc Thorac Surg.
15:1013–1018. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ghamri R and Alsulami H: Intravenous iron
versus oral iron administration for the treatment of iron
deficiency anemia: A patient-preference study. Cureus.
16(e65505)2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Henry DH, Dahl NV, Auerbach M,
Tchekmedyian S and Laufman LR: Intravenous ferric gluconate
significantly improves response to epoetin alfa versus oral iron or
no iron in anemic patients with cancer receiving chemotherapy.
Oncologist. 12:231–242. 2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Howaldt S, Domènech E, Martinez N, Schmidt
C and Bokemeyer B: Long-Term effectiveness of oral ferric maltol vs
intravenous ferric carboxymaltose for the treatment of
iron-deficiency anemia in patients with inflammatory bowel disease:
A randomized controlled noninferiority trial. Inflamm Bowel Dis.
28:373–384. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Iyoke CA, Emegoakor FC, Ezugwu EC, Lawani
LO, Ajah LO, Madu JA, Ezegwui HU and Ezugwu FO: Effect of treatment
with single total-dose intravenous iron versus daily oral
iron(III)-hydroxide polymaltose on moderate puerperal
iron-deficiency anemia. Ther Clin Risk Manag. 13:647–653.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jenq CC, Tian YC, Wu HH, Hsu PY, Huang JY,
Chen YC, Fang JT and Yang CW: Effectiveness of oral and intravenous
iron therapy in haemodialysis patients. Int J Clin Pract.
62:416–422. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Johnson DW: Intravenous versus oral iron
supplementation in peritoneal dialysis patients. Perit Dial Int. 27
(Suppl 2):S255–S260. 2007.PubMed/NCBI
|
|
24
|
Keeler BD, Simpson JA, Ng O, Padmanabhan
H, Brookes MJ and Acheson AG: IVICA Trial Group. Randomized
clinical trial of preoperative oral versus intravenous iron in
anaemic patients with colorectal cancer. Br J Surg. 104:214–221.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Khalil A, Goodhand JR, Wahed M, Yeung J,
Ali FR and Rampton DS: Efficacy and tolerability of intravenous
iron dextran and oral iron in inflammatory bowel disease: A
case-matched study in clinical practice. Eur J Gastroenterol
Hepatol. 23:1029–1035. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lindgren S, Wikman O, Befrits R, Blom H,
Eriksson A, Grännö C, Ung KA, Hjortswang H, Lindgren A and Unge P:
Intravenous iron sucrose is superior to oral iron sulphate for
correcting anaemia and restoring iron stores in IBD patients: A
randomized, controlled, evaluator-blind, multicentre study. Scand J
Gastroenterol. 44:838–845. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Macdougall IC, Bock AH, Carrera F, Eckardt
KU, Gaillard C, Van Wyck D, Roubert B, Nolen JG and Roger SD:
FIND-CKD Study Investigators. FIND-CKD: A randomized trial of
intravenous ferric carboxymaltose versus oral iron in patients with
chronic kidney disease and iron deficiency anaemia. Nephrol Dial
Transplant. 29:2075–2084. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mafodda A, Giuffrida D, Prestifilippo A,
Azzarello D, Giannicola R, Mare M and Maisano R: Oral sucrosomial
iron versus intravenous iron in anemic cancer patients without iron
deficiency receiving darbepoetin alfa: A pilot study. Support Care
Cancer. 25:2779–2786. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Montano-Pedroso JC, Garcia EB, de Moraes
MAR, Veiga DF and Ferreira LM: Intravenous iron sucrose versus oral
iron administration for the postoperative treatment of
post-bariatric abdominoplasty anaemia: An open-label, randomised,
superiority trial in Brazil. Lancet Haematol. 5:e310–e320.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mudge DW, Tan KS, Miles R, Johnson DW,
Badve SV, Campbell SB, Isbel NM, van Eps CL and Hawley CM: A
randomized controlled trial of intravenous or oral iron for
posttransplant anemia in kidney transplantation. Transplantation.
93:822–826. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Noronha V, Joshi A, Patil VM, Banavali SD,
Gupta S, Parikh PM, Marfatia S, Punatar S, More S, Goud S, et al:
Phase III randomized trial comparing intravenous to oral iron in
patients with cancer-related iron deficiency anemia not on
erythropoiesis stimulating agents. Asia Pac J Clin Oncol.
14:e129–e137. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Pisani A, Riccio E, Sabbatini M, Andreucci
M, Del Rio A and Visciano B: Effect of oral liposomal iron versus
intravenous iron for treatment of iron deficiency anaemia in CKD
patients: A randomized trial. Nephrol Dial Transplant. 30:645–652.
2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Short V, Allen R, Earley CJ, Bahrain H,
Rineer S, Kashi K, Gerb J and Auerbach M: A randomized double-blind
pilot study to evaluate the efficacy, safety, and tolerability of
intravenous iron versus oral iron for the treatment of restless
legs syndrome in patients with iron deficiency anemia. Am J
Hematol. 99:1077–1083. 2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Stoves J, Inglis H and Newstead CG: A
randomized study of oral vs intravenous iron supplementation in
patients with progressive renal insufficiency treated with
erythropoietin. Nephrol Dial Transplant. 16:967–974.
2001.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Van Wyck DB, Roppolo M, Martinez CO, Mazey
RM and McMurray S: United States Iron Sucrose (Venofer) Clinical
Trials Group. A randomized, controlled trial comparing IV iron
sucrose to oral iron in anemic patients with nondialysis-dependent
CKD. Kidney Int. 68:2846–2856. 2005.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu LM and Wu DP: Application progress of
high-dose intravenous iron in the treatment of iron deficiency
anemia. Zhonghua Xue Ye Xue Za Zhi. 43:960–963. 2022.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
37
|
Adhikary L and Acharya S: Efficacy of IV
iron compared to oral iron for increment of haemoglobin level in
anemic chronic kidney disease patients on erythropoietin therapy.
JNMA J Nepal Med Assoc. 51:133–136. 2011.PubMed/NCBI
|
|
38
|
Zhang Q, Wang H, Zhang YM, Li XL, Shen YY,
Wei N, Zou K, Su WX, Dai HP, Wu DP and Liu LM: Comparison of the
efficacy and safety between high-dose intravenous iron and oral
iron in treating iron deficiency anemia: a multicenter,
prospective, open-label, randomized controlled study. Zhonghua Xue
Ye Xue Za Zhi. 45:1113–1118. 2024.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
39
|
Gilreath JA and Rodgers GM: How I treat
cancer-associated anemia. Blood. 136:801–813. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Richards T, Baikady RR, Clevenger B,
Butcher A, Abeysiri S, Chau M, Macdougall IC, Murphy G, Swinson R,
Collier T, et al: Preoperative intravenous iron to treat anaemia
before major abdominal surgery (PREVENTT): A randomised,
double-blind, controlled trial. Lancet. 396:1353–1361.
2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Pasricha SR, Flecknoe-Brown SC, Allen KJ,
Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R,
Thomson AR, et al: Diagnosis and management of iron deficiency
anaemia: A clinical update. Med J Aust. 193:525–532.
2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Tolkien Z, Stecher L, Mander AP, Pereira
DI and Powell JJ: Ferrous sulfate supplementation causes
significant gastrointestinal side-effects in adults: A systematic
review and meta-analysis. PLoS One. 10(e0117383)2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Geisser P and Burckhardt S: The
pharmacokinetics and pharmacodynamics of iron preparations.
Pharmaceutics. 3:12–33. 2011.PubMed/NCBI View Article : Google Scholar
|
